NCT00774280View on ClinicalTrials.gov

Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2010

Conditions
LeukemiaMyelodysplastic Syndrome
Interventions
DRUG

BuCy vs BuFlu

Arm 1:BuCy Arm 2:BuFlu

Trial Locations (1)

138-736

Asan Medical Center, Seoul

All Listed Sponsors
lead

Cooperative Study Group A for Hematology

NETWORK

NCT00774280 - Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen | Biotech Hunter | Biotech Hunter